http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1561227-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3469749340c7eb151141a9b108a44108 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
filingDate | 1988-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1994-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce678407ffcd5f1e9ae30e1e547ef6bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0422d1a1a6921d6bc19ff787fbe4535d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d699b5a873d4da1a46cdc57688c1cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2bebc9f49d06a3697d7eed0314041e2 |
publicationDate | 1994-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-1561227-C |
titleOfInvention | Aqueous solution for platelet cryoconservation |
abstract | FIELD: medicine. SUBSTANCE: solution for cryoconservation of platelets contains hexamethylenebistetrahydroxyethylurea, citric acid and ethylenediaminetetraacetic acid disodiun salt at the following ratio of components, wt. -% : hexamethylenebistetrahydroxyethylurea 5-15; citric acid 0.9-1.3; ethylenediaminetetraacetic acid disodium salt 0.1-1.0, and water for injection - the rest. Solution is used for blood cells conservation. EFFECT: decreased death of platelets, increased platelet quantity in functionally active state, decreased toxicity of cryoprotective solution. 3 tbl |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2477953-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2530149-C1 |
priorityDate | 1988-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.